Watch exclusive previews from our distinguished speakers and get ready for cutting-edge insights at AD/PD™ 2026!
Dr. Ornit Chiba-Falek
EMPOWERING SINGLE-CELL MULTI-OMICS IN ALZHEIMER’S RESEARCH: MECHANISTIC INSIGHTS AND TRANSLATIONAL APPLICATIONS
Dr. Joanna Jankowsky
TRANSLATIONAL DRUG DISCOVERY AND MODELS
Dr. Sterling Johnson
TEMPORAL INSIGHTS FROM AD AND NON AD BIOMARKERS ON THE SPEED OF PROGRESSION THROUGH THE CLINICAL STAGES OF AD
Dr. Roy N Alcalay
TOWARDS PRECISION MEDICINE IN GENETIC PARKINSON’S DISEASE
Dr. Robert Vassar
MECHANISTIC INSIGHTS INTO THE CONNECTION BETWEEN ABETA AND TAU
Prof. Dan Frenkel
THE LINK BETWEEN SENESCENT GLIA TO NEURODEGENERATION IN AD
Prof. Johannes Streffer
FORUM 04: TARGETS TO THERAPIES: TRANSLATIONAL R&D FOR Α-SYNUCLEIN, LRRK2, AND GBA PATHOLOGIES IN PD, LBD, AND MSA
Prof. Giovanni Frisoni
FORUM 03: REWIRING COGNITION: TARGETING CHOLINERGIC, SYNAPTIC, AND NETWORK-BASED MECHANISMS IN AD, PD, AND LBD
Prof. Fabrizio Stocchi
CAN WE PREVENT PARKINSON’S DISEASE?
Dr. Costantino Iadecola
UNTANGLING MIXED DEMENTIA: A NEUROVASCULAR LENS ON PATHOBIOLOGY
Dr. Michael Schlossmacher
PREDICTING THE ONSET OF PARKINSON’S: ARE WE THERE YET?
Dr. Kanta Horie
FORUM 01: BIOMARKERS TO BENEFIT: ACCELERATING TRANSLATION OF MULTI-MODAL BIOMARKERS INTO DISEASE-MODIFYING THERAPIES
Dr. Sid O'Bryant
ALZHEIMER’S DISEASE BIOMARKERS AMONG DIVERSE POPULATIONS – FINDINGS FROM THE HABS-HD STUDY
Prof. Hermona Soreq
TRANSFER RNA FRAGMENTS AS EARLY PREDICTORS OF AD AND PD
Dr. Lea Grinberg
UNDERSTANDING NEURODEGENERATIVE DISEASES TODAY: LESSONS FROM CLINICOPATHOLOGICAL CORRELATIONS AND THE ONGOING ROLE OF NEUROPATHOLOGY IN THE BIOMARKER AGE
Prof. Tiago Outeiro
MOLECULAR EFFECTS OF NOVEL ALPHA-SYNUCLEIN MUTATIONS
Dr. Christian Hölscher
FORUM 06: BEYOND AMYLOID AND TAU: EMERGING TARGETS AND MULTI-PATHWAY APPROACHES IN NEURODEGENERATION AND NEUROINFLAMMATION – PROMISE AND PITFALLS